Identifier
Created
Classification
Origin
09BRUSSELS1104
2009-08-10 15:48:00
UNCLASSIFIED
Embassy Brussels
Cable title:
BELGIUM ESTIMATES 900 NEW CASES OF H1N1; VACCINE TESTS
how-toVZCZCXRO8880 RR RUEHAG RUEHAST RUEHDA RUEHDBU RUEHDF RUEHFL RUEHIK RUEHKW RUEHLA RUEHLN RUEHLZ RUEHNP RUEHPOD RUEHROV RUEHSK RUEHSL RUEHSR RUEHVK RUEHYG DE RUEHBS #1104 2221548 ZNR UUUUU ZZH R 101548Z AUG 09 ZDK FM AMEMBASSY BRUSSELS TO RUEHC/SECSTATE WASHDC 9333 RUEAUSA/HHS WASHDC RUEHPH/CDC ATLANTA GA INFO RUEHZL/EUROPEAN POLITICAL COLLECTIVE
UNCLAS BRUSSELS 001104
SIPDIS
STATE FOR OES/IHB
STATE PASS USTR JANE DOHERTY
STATE PASS USAID
STATE PASS HHS/NIH
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC AMED CASC KFLO TBIO KSAF KPAO PREL
PINR, AMGT, TF, BE
SUBJECT: BELGIUM ESTIMATES 900 NEW CASES OF H1N1; VACCINE TESTS
BEGIN
SUMMARY
-------
UNCLAS BRUSSELS 001104
SIPDIS
STATE FOR OES/IHB
STATE PASS USTR JANE DOHERTY
STATE PASS USAID
STATE PASS HHS/NIH
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC AMED CASC KFLO TBIO KSAF KPAO PREL
PINR, AMGT, TF, BE
SUBJECT: BELGIUM ESTIMATES 900 NEW CASES OF H1N1; VACCINE TESTS
BEGIN
SUMMARY
--------------
1. (U) Belgian health authorities announced on August 7 an
estimated 900 new cases of H1N1 in Belgium for the first week of
August. The weekly estimate indicates the virus is spreading at
predicted levels. Belgian media report that tests of H1N1 vaccines
have begun on volunteers at several Belgian universities. In a
press release on August 6, the Belgian Influenza Commission reminded
the public that the distribution of antiviral medication is
following the planned procedure and that drugs will remain freely
available for patients of at-risk groups. End summary.
H1N1 AT NORMAL LEVELS -- GOVERNMENT
--------------
2. (U) The Belgian Influenza Commission estimates that some 900 new
cases of H1N1 were registered in Belgium during the first week of
August. The estimate is based on information collected voluntarily
by a network of 180 General Practitioners (GPs) whose patients
comprise a representative sample of the Belgian population. In
Belgium the incidence of the flu is still at normal levels for this
time of the year and the information collected by the network of GPs
indicates that the virus is spreading at a rate similar to weeks
previous and not yet increasing.
FIRST TESTS OF H1N1 VACCINES
--------------
3. (U) Belgian press reported on August 10 that vaccines against
H1N1 are being tested for the first time in hospitals in Antwerp and
Ghent on some 600 healthy volunteers. The test vaccines developed
by Novartis will contain different doses of the influenza virus so
that researchers can determine the most effective composition.
Belgian newspapers report that the first vaccines against H1N1
should be on the market in Belgium in October if everything goes
according to plan.
DISTRIBUTION OF ANTIVIRALS GOING AS PLANNED
--------------
4. (U) In an August 6 press release the Belgian Influenza
Commission reminded the Belgian public and GPs that the distribution
of antiviral medication continues to follow the planned procedure:
a GP who determines that a patient belongs to a known risk group and
would therefore benefit from a treatment of antiviral medication can
obtain the necessary drugs through municipal medical inspectors.
Antiviral medication continues to be free for all at-risk patients
in Belgium.
BUSH
SIPDIS
STATE FOR OES/IHB
STATE PASS USTR JANE DOHERTY
STATE PASS USAID
STATE PASS HHS/NIH
E.O. 12958: N/A
TAGS: KFLU AEMR ASEC AMED CASC KFLO TBIO KSAF KPAO PREL
PINR, AMGT, TF, BE
SUBJECT: BELGIUM ESTIMATES 900 NEW CASES OF H1N1; VACCINE TESTS
BEGIN
SUMMARY
--------------
1. (U) Belgian health authorities announced on August 7 an
estimated 900 new cases of H1N1 in Belgium for the first week of
August. The weekly estimate indicates the virus is spreading at
predicted levels. Belgian media report that tests of H1N1 vaccines
have begun on volunteers at several Belgian universities. In a
press release on August 6, the Belgian Influenza Commission reminded
the public that the distribution of antiviral medication is
following the planned procedure and that drugs will remain freely
available for patients of at-risk groups. End summary.
H1N1 AT NORMAL LEVELS -- GOVERNMENT
--------------
2. (U) The Belgian Influenza Commission estimates that some 900 new
cases of H1N1 were registered in Belgium during the first week of
August. The estimate is based on information collected voluntarily
by a network of 180 General Practitioners (GPs) whose patients
comprise a representative sample of the Belgian population. In
Belgium the incidence of the flu is still at normal levels for this
time of the year and the information collected by the network of GPs
indicates that the virus is spreading at a rate similar to weeks
previous and not yet increasing.
FIRST TESTS OF H1N1 VACCINES
--------------
3. (U) Belgian press reported on August 10 that vaccines against
H1N1 are being tested for the first time in hospitals in Antwerp and
Ghent on some 600 healthy volunteers. The test vaccines developed
by Novartis will contain different doses of the influenza virus so
that researchers can determine the most effective composition.
Belgian newspapers report that the first vaccines against H1N1
should be on the market in Belgium in October if everything goes
according to plan.
DISTRIBUTION OF ANTIVIRALS GOING AS PLANNED
--------------
4. (U) In an August 6 press release the Belgian Influenza
Commission reminded the Belgian public and GPs that the distribution
of antiviral medication continues to follow the planned procedure:
a GP who determines that a patient belongs to a known risk group and
would therefore benefit from a treatment of antiviral medication can
obtain the necessary drugs through municipal medical inspectors.
Antiviral medication continues to be free for all at-risk patients
in Belgium.
BUSH